ATACAND 32 MG 14 TAB ALFA-DORNASA Pacientes previamente tratados con trastuzumab

Description

Pacientes previamente tratados con trastuzumab y un taxano

XOLAIR 150 MG/1

PRINCIPIO ACTIVO: CILOSTAZOL

Indicado para lactantes de 0 a 6 meses

Leflunomida 20 mg

ATACAND 32 MG 14 TAB ALFA-DORNASA Pacientes previamente tratados con trastuzumabSUSTANCIA: ATACAND TAB. 32 MG. CAJA C 14 FABRICANTE: ASTRA ZENECA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy